Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study

Tim A. C. de Vries; Martin E. W. Hemels; Frank Cools; Harry J. G. M. Crijns; Laetitia Yperzeele; Peter Vanacker; Ivan Blankoff; Patrizio Lancellotti; Georges H. Mairesse; Anne de Veer; Ruben Casado Arroyo; Emmanuel Catez; Michel de Pauw; Thomas Vanassche; Carlo de Asmundis; Paulus Kirchhof; Raffaele De Caterina; Joris R. de Groot; ETNA-AF-Europe principal investigators from Belgium and the Netherlands

doi:10.1080/00015385.2020.1746095

Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study

Tim A. C. de Vries^*, Martin E. W. Hemels, Frank Cools, Harry J. G. M. Crijns, Laetitia Yperzeele, Peter Vanacker, Ivan Blankoff, Patrizio Lancellotti, Georges H. Mairesse, Anne de Veer, Ruben Casado Arroyo, Emmanuel Catez, Michel de Pauw, Thomas Vanassche, Carlo de Asmundis, Paulus Kirchhof, Raffaele De Caterina, Joris R. de Groot, ETNA-AF-Europe principal investigators from Belgium and the Netherlands

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	431-439
Number of pages	9
Journal	Acta Cardiologica
Volume	76
Issue number	4
Early online date	29 Dec 2020
DOIs	https://doi.org/10.1080/00015385.2020.1746095
Publication status	Published - 4 Jul 2021

Keywords

anticoagulants
haemorrhage
off-label use
clinical trial
phase IV
stroke
thromboembolism

Access to Document

10.1080/00015385.2020.1746095

Cite this

de Vries, T. A. C., Hemels, M. E. W., Cools, F., Crijns, H. J. G. M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G. H., de Veer, A., Casado Arroyo, R., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J. R., & ETNA-AF-Europe principal investigators from Belgium and the Netherlands (2021). Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study. Acta Cardiologica, 76(4), 431-439. https://doi.org/10.1080/00015385.2020.1746095

de Vries, Tim A. C. ; Hemels, Martin E. W. ; Cools, Frank ; Crijns, Harry J. G. M. ; Yperzeele, Laetitia ; Vanacker, Peter ; Blankoff, Ivan ; Lancellotti, Patrizio ; Mairesse, Georges H. ; de Veer, Anne ; Casado Arroyo, Ruben ; Catez, Emmanuel ; de Pauw, Michel ; Vanassche, Thomas ; de Asmundis, Carlo ; Kirchhof, Paulus ; De Caterina, Raffaele ; de Groot, Joris R. ; ETNA-AF-Europe principal investigators from Belgium and the Netherlands. / Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands : insights from the ETNA-AF-Europe study. In: Acta Cardiologica. 2021 ; Vol. 76, No. 4. pp. 431-439.

@article{e03581096f134ecd99b90e2521732ffb,

title = "Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study",

keywords = "anticoagulants, haemorrhage, off-label use, clinical trial, phase IV, stroke, thromboembolism",

author = "{de Vries}, {Tim A. C.} and Hemels, {Martin E. W.} and Frank Cools and Crijns, {Harry J. G. M.} and Laetitia Yperzeele and Peter Vanacker and Ivan Blankoff and Patrizio Lancellotti and Mairesse, {Georges H.} and {de Veer}, Anne and {Casado Arroyo}, Ruben and Emmanuel Catez and {de Pauw}, Michel and Thomas Vanassche and {de Asmundis}, Carlo and Paulus Kirchhof and {De Caterina}, Raffaele and {de Groot}, {Joris R.} and {ETNA-AF-Europe principal investigators from Belgium and the Netherlands}",

year = "2021",

month = jul,

day = "4",

doi = "10.1080/00015385.2020.1746095",

language = "English",

volume = "76",

pages = "431--439",

journal = "Acta Cardiologica",

issn = "0001-5385",

publisher = "Routledge/Taylor & Francis Group",

number = "4",

}

de Vries, TAC, Hemels, MEW, Cools, F, Crijns, HJGM, Yperzeele, L, Vanacker, P, Blankoff, I, Lancellotti, P, Mairesse, GH, de Veer, A, Casado Arroyo, R, Catez, E, de Pauw, M, Vanassche, T, de Asmundis, C, Kirchhof, P, De Caterina, R, de Groot, JR & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021, 'Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study', Acta Cardiologica, vol. 76, no. 4, pp. 431-439. https://doi.org/10.1080/00015385.2020.1746095

Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands : insights from the ETNA-AF-Europe study. / de Vries, Tim A. C.; Hemels, Martin E. W.; Cools, Frank; Crijns, Harry J. G. M.; Yperzeele, Laetitia; Vanacker, Peter; Blankoff, Ivan; Lancellotti, Patrizio; Mairesse, Georges H.; de Veer, Anne; Casado Arroyo, Ruben; Catez, Emmanuel; de Pauw, Michel; Vanassche, Thomas; de Asmundis, Carlo; Kirchhof, Paulus; De Caterina, Raffaele; de Groot, Joris R.; ETNA-AF-Europe principal investigators from Belgium and the Netherlands.

In: Acta Cardiologica, Vol. 76, No. 4, 04.07.2021, p. 431-439.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands

T2 - insights from the ETNA-AF-Europe study

AU - de Vries, Tim A. C.

AU - Hemels, Martin E. W.

AU - Cools, Frank

AU - Crijns, Harry J. G. M.

AU - Yperzeele, Laetitia

AU - Vanacker, Peter

AU - Blankoff, Ivan

AU - Lancellotti, Patrizio

AU - Mairesse, Georges H.

AU - de Veer, Anne

AU - Casado Arroyo, Ruben

AU - Catez, Emmanuel

AU - de Pauw, Michel

AU - Vanassche, Thomas

AU - de Asmundis, Carlo

AU - Kirchhof, Paulus

AU - De Caterina, Raffaele

AU - de Groot, Joris R.

AU - ETNA-AF-Europe principal investigators from Belgium and the Netherlands

PY - 2021/7/4

Y1 - 2021/7/4

KW - anticoagulants

KW - haemorrhage

KW - off-label use

KW - clinical trial

KW - phase IV

KW - stroke

KW - thromboembolism

U2 - 10.1080/00015385.2020.1746095

DO - 10.1080/00015385.2020.1746095

M3 - Article

C2 - 33406996

VL - 76

SP - 431

EP - 439

JO - Acta Cardiologica

JF - Acta Cardiologica

SN - 0001-5385

IS - 4

ER -